U.S. Asthma/COPD Market

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service covers the U.S. asthma/COPD market from 2003-2013. Included are a therapeutic overview, patient forecasts, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product class: bronchodilators, anti-inflammatories, and combination therapies. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.

Table of Contents

U.S. Asthma/COPD Market, Executive SummaryExecutive SummaryIntroductionU.S. Asthma/COPD Market, Market IntroductionOverviewScope and SegmentationResearch MethodologyDisease OverviewAsthmaCOPDTreatment OptionsMarket OverviewMarket Engineering MeasurementsIndustry Challenges and Strategic RecommendationsMarket DriversMarket RestraintsU.S. Asthma/COPD Market, Total Market AnalysisCompetitive AnalysisCompetitive StructurePatient ForecastsPatient Forecasts - AsthmaPatient Forecasts - COPDTotal Patient ForecastsRevenue ForecastsTotal Market Revenue ForecastsMarket Share AnalysisU.S. Asthma/COPD Market, Bronchodilators MarketIntroductionIntroductionMarket Engineering MeasurementsRevenue ForecastsMarket Share AnalysisShort-Acting Beta-2 Agonists MarketIntroductionRevenue ForecastsProduct AnalysisPipeline AnalysisLong-Acting Beta-2 Agonists MarketIntroductionRevenue ForecastsProduct AnalysisPipeline AnalysisAnticholinergics MarketIntroductionRevenue ForecastsProduct AnalysisPipeline AnalysisCombination BronchodilatorsIntroductionRevenue ForecastsProduct AnalysisPipeline AnalysisU.S. Asthma/COPD Market, Anti-Inflammatory MarketIntroductionIntroductionMarket Engineering MeasurementsRevenue ForecastsMarket Share AnalysisInhaled Corticosteroids MarketIntroductionRevenue ForecastsProduct AnalysisPipeline AnalysisMediator-Release Inhibitor MarketIntroductionRevenue ForecastsProduct AnalysisPipeline AnalysisAnti-Leukotriene MarketIntroductionRevenue ForecastsProduct AnalysisPipeline AnalysisMonoclonal Antibody MarketIntroductionRevenue ForecastsProduct AnalysisPipeline AnalysisOther Emerging Anti-InflammatoriesPipeline AnalysisU.S. Asthma/COPD Market, Combination Therapies MarketCombination TherapiesIntroductionMarket Engineering MeasurementsRevenue ForecastsProduct AnalysisPipeline AnalysisU.S. Asthma/COPD Market, AppendixDecision Support DatabasesMortality Due to Asthma Bronchitis and EmphysemaPrevalence of AsthmaPrevalence of Chronic Obstructive Pulmonary DiseaseFemale Population 65 and AboveMale Population 65 and Above




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 21-Nov-17

Region : North America

Release Date : 20-Nov-17

Region : North America

Release Date : 20-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.